Business Wire

Loop Energy and Fraunhofer ISE Testing Demonstrates the Potential of Innovative eFlow™ Flow Field Design to Increase Hydrogen Production in Electrolyzers

6.3.2023 14:30:00 EET | Business Wire | Press release

Share

Loop Energy (TSX: LPEN), a designer and manufacturer of hydrogen fuel cell solutions, has completed third-party validation of the use of its patented eFlow technology in PEM electrolyzers. In partnership with Fraunhofer USA, testing was conducted by the German Fraunhofer Institute for Solar Energy Systems ISE, and has demonstrated a fuel cell architecture with trapezoid flow field design can enhance temperature uniformity. When incorporated into conventional PEM electrolysis cells, this bipolar plate architecture demonstrates it can increase hydrogen production. Loop Energy is now seeking industry partners to develop a full-scale electrolyzer prototype for commercial validation.

Results show that eFlow architecture creates a more stable and uniform operating environment in the PEM water electrolysis test cells compared to conventional flow fields with parallel channels, resulting in greater hydrogen production and improved efficiency. Testing also shows the enhanced uniform operating environment should have a beneficial impact on durability.

“Results from the validation process show that the new flow field technology has the potential to surpass typical levels of hydrogen production that we see in the industry today and supports green hydrogen production to become increasingly economically viable,” said Fraunhofer ISE Head of Department Chemical Energy Storage, Dr. Tom Smolinka. “The difference we have seen from current electrolyzer performance with conventional parallel flow field is that the adapted design appears to create more uniform temperature distribution could make it an enabling technology for some of the advanced materials needed to really increase the economics of electrolyzers and green hydrogen.”

Encouraged by the results, Loop Energy and Fraunhofer ISE are inviting expressions of interest from potential industry partners. Interested parties will partner with the two companies in designing and manufacturing an electrolyzer prototype to verify eFlow’s benefits for producing hydrogen on a commercial scale. All expressions of interest can be directed to Loop Energy Chief Commercial Officer, George Rubin.

“The completion of third-party validation is an important milestone for Loop Energy as we explore how eFlow can transform the hydrogen production sector,” said Loop Energy President & CEO, Ben Nyland. “We’re extremely pleased to partner with Fraunhofer ISE and draw on their long-lasting experience in cell and stack design for PEM water electrolysis. The results have been encouraging, and we’re excited to begin the search for strategic partners to support us as we innovate electrolyzer technology.”

Currently, Loop Energy’s proprietary eFlow technology is applied in its fuel cell products to offer unmatched levels of fuel efficiency. Its tapering channel design enables eFlow to provide improved uniform current density and increases gas velocity to deliver superior thermal and water management. With the new discovery that eFlow can benefit hydrogen production efficiency, it expands the patented technology’s potential use across the hydrogen energy vertical.

Global demand for hydrogen production is projected to grow by more than US$1 trillion by 20501. As a result, both new and existing hydrogen producers are searching for a competitive advantage to meet rising demand.

Ben Nyland will share details of this development at CERAWeek on March 6 and 7 alongside Thomas Schuelke, president of Fraunhofer USA, which also acts as project partner. In addition, Dr. Tom Smolinka and Loop Energy Chief Scientist, Dr. Sean Mackinnon will present the technical results at Hannover Messe on April 17. Requests for meetings at either event can be coordinated with Ethan Hugh.

Loop Energy’s management team will share more details on its end of year financial results call on March 30. Call details can be found on Loop Energy’s website.

About Fraunhofer ISE

The Fraunhofer-Gesellschaft, based in Germany, is the world's leading organization for application-oriented research. With its focus on key technologies of relevance to the future and on the exploitation of results in business and industry, it plays a central role in the innovation process. As a guide and stimulus for innovative developments and scientific excellence, it helps shape our society and our future. Founded in 1949, the organization currently operates 76 institutes and research facilities in Germany. More than 30,000 employees, most of them trained in the natural sciences or engineering, produce the annual research volume of 2.9 billion euros. Of this, 2.5 billion euros is spent on contract research. Further information: www.ise.fraunhofer.de/en

About Fraunhofer USA

Fraunhofer USA, Inc., a legally independent US affiliate founded by Fraunhofer-Gesellschaft, is an R&D organization working with industry, universities, and state and federal governments on contract R&D projects. Fraunhofer is in the high-tech problem-solving business and utilizes world class scientific and engineering expertise to engage in complex R&D projects across many different disciplines. Through Fraunhofer USA, U.S. clients can connect to the 79 research units throughout the U.S. and Germany with over 30,000 employees, predominantly scientists and engineers. www.fraunhofer.org

About Loop Energy Inc.

Loop Energy is a leading designer and manufacturer of hydrogen fuel cell systems targeted for the electrification of commercial vehicles, including light commercial vehicles, transit buses and medium and heavy-duty trucks. Loop Energy’s products feature the company’s proprietary eFlow™ technology in the fuel cell stack’s bipolar plates. eFlow is designed to enable commercial customers to achieve performance maximization and cost minimization. Loop Energy works with OEMs and major vehicle sub-system suppliers to enable the production of hydrogen fuel cell electric vehicles. For more information about how Loop Energy is driving towards a zero-emissions future, visit www.loopenergy.com.

Forward Looking Warning

This press release contains forward-looking information within the meaning of applicable securities legislation, which reflect management’s current expectations and projections regarding future events. Particularly, statements regarding the Company’s expectations of future results, performance, achievements, prospects or opportunities or the markets in which we operate is forward-looking information, including without limitation, purchase orders, cost reduction, profitability and revenue targets; our future growth prospects and business outlook including without limitation the expected demand for our products, the allocation of resources and funds, the expected timeline for profitability, the planned growth of our customer base and the expected growth of our operations globally. Forward-looking information is based on a number of assumptions (including without limitation assumptions with respect the current and future performance of the Company’s products, growth in demand for the Company’s products, the Company’s ability to execute on its strategy, achieve its targets and progress existing and future customers through the Customer Adoption Cycle in a timely way, and is subject to a number of risks and uncertainties, many of which are beyond the Company’s control and could cause actual results and events to vary materially from those that are disclosed, or implied, by such forward-looking information.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Loop Energy Investor Inquiries:
Natalie Arseneau | Tel: +1 604.222.3400 Ext. 418 | investors@loopenergy.com

Loop Energy Business Inquiries:
George Rubin | Tel: +1.604.828.8185 | grubin@loopenergy.com

Loop Energy Media Inquiries:
Ethan Hugh | Tel: +1 604.306.4277| ethan.hugh@loopenergy.com
Lucas Schmidt | Tel: +1.778.791.8756 | lucas.schmidt@loopenergy.com

Fraunhofer ISE Inquiries:
Dr. Tom Smolinka | Tel: +49.761.4588.5212 | tom.smolinka@ise.fraunhofer.de
Diana Bribach | Tel: +49.761.4588.2804 | diana.bribach@ise.fraunhofer.de

Fraunhofer USA Inquiries:
Elliott Sprehe | Tel: +734.927.3984 | esprehe@fraunhofer.org

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

VerSprite Launches Fork and Knife: AI-Driven Threat Modeling and Adversarial Testing Built for the Speed of Modern Software27.6.2026 00:28:00 EEST | Press release

VerSprite, a global leader in risk-based threat modeling and the firm behind the PASTA (Process for Attack Simulation and Threat Analysis) methodology, today announced the general availability of Fork (www.forktm.com), a continuous application threat modeling platform, alongside Knife, an AI-led, human-on-the-loop adversarial testing platform for web applications and web API endpoints. Together, the two products operationalize a new model for product security—one where applications are securely designed, continuously modeled, and actively tested as part of the build process itself. The launch addresses a problem every security leader knows but few tools have solved: threat modeling is essential, never more so than in an AI-driven era, yet it has remained slow, manual, and anchored to frameworks designed for a different threat landscape. The problem: threat modeling matters more than ever—and most tools are stuck in 2005 For two decades, application threat modeling has leaned heavily on

Venture Global Announces Closing of $1.5 Billion Senior Secured Vessel Financing Facility26.6.2026 23:30:00 EEST | Press release

Venture Global, Inc. (NYSE: VG) announced today that its wholly-owned subsidiary, Venture Global Shipping Holdings, LLC (“VGSH”), has entered into a Credit and Guaranty Agreement providing for a senior secured term loan facility (the “Facility”) in an aggregate principal amount of up to $1,500,000,000. The Facility will mature on June 26, 2032. Deutsche Bank and ING acted as coordinating lead arrangers for the Facility. ING also serves as facility agent and security trustee. VGSH intends to use the net proceeds from the Facility for general corporate purposes, including to reimburse Venture Global LNG, Inc. for payments previously made by it or its affiliates in connection with the acquisition of nine LNG carriers, funding certain reserve accounts, and paying transaction fees and expenses. About Venture Global Venture Global is an American producer and exporter of low-cost U.S. liquefied natural gas (“LNG”) with over 100 MTPA of capacity in production, construction, or development. Ven

Capco Recognized by OpenAI for Innovation and Responsible AI Leadership26.6.2026 21:00:00 EEST | Press release

Global management and technology consultancy Capco, a Wipro company,has been recognized by OpenAI for both AI innovation and responsible AI leadership. Capco received the AI Governance & Risk Excellence Award at the recent OpenAI Partner Summit 2026 in San Francisco, highlighting Capco’s ability to deliver enterprise-grade AI outcomes in highly regulated environments. The award recognizes Capco’s expert advantage when helping financial services and energy organizations to scale AI with confidence, balancing innovation with strong governance to reduce risk, strengthen compliance and improve customer outcomes. This award follows Capco winning the OpenAI Codex Hackathon, where its UK AI Lab competed against more than 30 teams and over 100 participants from across the OpenAI partner ecosystem. Capco's winning entry Sentra – a consulting-led, AI-powered retail banking solution – uses digital twin technology to identify vulnerable customers and recommend explainable next-best actions for fro

Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release

Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o

Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release

Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye